Technical Analysis for SNPHY - Santen Pharmaceutical Co

Grade Last Price % Change Price Change
grade C 17.9175 0.15% 0.0275
SNPHY closed up 0.15 percent on Wednesday, July 8, 2020, on approximately normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Down Down
Historical SNPHY trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Fell Below 200 DMA Bearish 0.15%
Fell Below 50 DMA Bearish 0.15%
MACD Bearish Centerline Cross Bearish 0.15%
Gapped Down Weakness 0.15%
Pocket Pivot Bullish Swing Setup -2.14%
Narrow Range Bar Range Contraction -2.14%
Crossed Above 200 DMA Bullish -1.98%
Crossed Above 50 DMA Bullish -1.98%
Older signals for SNPHY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Santen Pharmaceutical Co., Ltd. researches and develops, produces, and markets pharmaceuticals and medical devices in Japan and internationally. It offers prescription pharmaceutical products for glaucoma and ocular hypertension, dry eyes, allergic conjunctivitis, severe keratitis with dry eyes, vernal keratoconjunctivitis, uveitis, wet age-related macular degeneration, and myopia; and over-the-counter pharmaceutical products. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.
Medicine Health Medical Specialties RTT Glaucoma Conjunctivitis Allergic Conjunctivitis Wet Age Related Macular Degeneration Markets Pharmaceuticals Ocular Hypertension Over The Counter Pharmaceutical Products Pharmaceuticals And Medical Devices Prescription Pharmaceutical Products Uveitis Keratoconjunctivitis Myopia Santen Pharmaceutical Severe Keratitis Vernal Keratoconjunctivitis

Is SNPHY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 20.18
52 Week Low 13.0
Average Volume 19,719
200-Day Moving Average 17.9186
50-Day Moving Average 18.1451
20-Day Moving Average 18.4868
10-Day Moving Average 18.3198
Average True Range 0.4023
ADX 15.34
+DI 26.2487
-DI 35.5706
Chandelier Exit (Long, 3 ATRs ) 18.0731
Chandelier Exit (Short, 3 ATRs ) 18.9069
Upper Bollinger Band 19.2480
Lower Bollinger Band 17.7256
Percent B (%b) 0.13
BandWidth 8.2351
MACD Line -0.0411
MACD Signal Line 0.0824
MACD Histogram -0.1235
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.2475
Resistance 3 (R3) 18.2383 18.1192 18.1925
Resistance 2 (R2) 18.1192 18.0351 18.1238 18.1742
Resistance 1 (R1) 18.0183 17.9832 17.9588 18.0275 18.1558
Pivot Point 17.8992 17.8992 17.8694 17.9038 17.8992
Support 1 (S1) 17.7983 17.8151 17.7388 17.8075 17.6792
Support 2 (S2) 17.6792 17.7632 17.6838 17.6608
Support 3 (S3) 17.5783 17.6792 17.6425
Support 4 (S4) 17.5875